EPA:ALDMS - Euronext Paris - Matif - FR0012202497 - Common Stock - Currency: EUR
EPA:ALDMS (3/7/2025, 7:00:00 PM)
1.065
+0.01 (+1.43%)
The current stock price of ALDMS.PA is 1.065 EUR. In the past month the price increased by 18.6%. In the past year, price decreased by -8.19%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 29.15 | 217.38B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 69.31 | 166.86B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 39.18 | 133.56B | ||
1BSX.MI | BOSTON SCIENTIFIC CORP | 39.52 | 133.38B | ||
1MDT.MI | MEDTRONIC PLC | 17.48 | 113.17B | ||
2M6.DE | MEDTRONIC PLC | 17.56 | 110.81B | ||
1SHL.MI | SIEMENS HEALTHINEERS AG | 25.27 | 60.49B | ||
BOX.DE | BECTON DICKINSON AND CO | 16.4 | 60.33B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
1EW.MI | EDWARDS LIFESCIENCES CORP | 26.07 | 39.21B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 26.65 | 37.76B | ||
DC4.DE | DEXCOM INC | 48.5 | 28.81B |
Diagnostic Medical Systems engages in the development, design, and production of medical imaging systems. The company is headquartered in Gallargues-Le-Montueux, Occitanie and currently employs 143 full-time employees. The firm manufactures a range of products for bone densitometry examination, including the ultrasound imaging system UBIS 5000, Challenger Envision, Stratos dR and Stratos. In the radiology sector, its products include Baccara dRF 43, EOL, Platinum and Da Vinci solutions, among others. In addition, it offers such products as scanners, transcranial Doppler, and Giotto Image mammography system. The firm operates several direct subsidiaries, AXS Medical, Apelem SAS, which manufactures radiology equipment, Medilink SARL, which produces Doppler and bone densitometry devices, Apelem SA, based in Spain, Alpha MOS based in France and one indirect subsidiary, SA Apelem and one indirect affiliated company, Spectrap.
DIAGNOSTIC MEDICAL SYSTEMS
9 Avenue du Canal Philippe
Gallargues-le-Montueux OCCITANIE FR
Employees: 134
Company Website: https://www.dms.com/
Investor Relations: http://www.dms.com/en/investors/
Phone: 33467504900
The current stock price of ALDMS.PA is 1.065 EUR. The price increased by 1.43% in the last trading session.
The exchange symbol of DIAGNOSTIC MEDICAL SYSTEMS is ALDMS and it is listed on the Euronext Paris - Matif exchange.
ALDMS.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ALDMS.PA and the average price target is 1.84 EUR. This implies a price increase of 72.39% is expected in the next year compared to the current price of 1.065. Check the DIAGNOSTIC MEDICAL SYSTEMS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) has a market capitalization of 19.28M EUR. This makes ALDMS.PA a Nano Cap stock.
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) currently has 134 employees.
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) has a support level at 1.01. Check the full technical report for a detailed analysis of ALDMS.PA support and resistance levels.
The Revenue of DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) is expected to grow by 10.02% in the next year. Check the estimates tab for more information on the ALDMS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALDMS.PA does not pay a dividend.
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).
ChartMill assigns a technical rating of 9 / 10 to ALDMS.PA. When comparing the yearly performance of all stocks, ALDMS.PA is one of the better performing stocks in the market, outperforming 91.36% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to ALDMS.PA. ALDMS.PA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ALDMS.PA reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS decreased by -1661.74% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -20.47% | ||
ROE | -91.77% | ||
Debt/Equity | 1.1 |
ChartMill assigns a Buy % Consensus number of 87% to ALDMS.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 100% and a revenue growth 10.02% for ALDMS.PA